OptimizeRx Reports Fourth Quarter and Full Year 2022 Financial Results

Go back to OptimizeRx Reports Fourth Quarter and Full Year 2022 Financial Results

Optimizerx Corporation (OPRX) Tops Q4 EPS by 1c; Guides Q1 Revenue Lower

March 8, 2023 4:05 PM EST

Optimizerx Corporation (NASDAQ: OPRX) reported Q4 EPS of $0.25, $0.01 better than the analyst estimate of $0.24. Revenue for the quarter came in at $19.7 million versus the consensus estimate of $21.77 million.

GUIDANCE:

Optimizerx Corporation sees Q1 2023 revenue of $11.5-13 million, versus the consensus of... More